Sort by:
Need a comprehensive medical report on "A"?
Analyze the latest clinical research and treatment options
Summarize scientific findings from medical journals
A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant
Not Applicable
Not yet recruiting
- Conditions
- Respiratory Syncytial Virus Infections
- Interventions
- Biological: Adjuvanted RSVPreF3 vaccine
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 234
- Registration Number
- NCT07092865
A Study Comparing Immediate Treatment to Deferred Treatment With the Fisher Wallace (FW) Stimulator FW-200 Device for the Treatment of Self-reported Anxiety in First Responders
Not Applicable
Completed
- Conditions
- Anxiety
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- Fisher Wallace Laboratories
- Target Recruit Count
- 220
- Registration Number
- NCT07093736
- Locations
- 🇺🇸
Florence Healthcare, Atlanta, Georgia, United States
🇺🇸Seattle Police Department Wellness Unit, Seattle, Washington, United States
A Study of MRG006A in the Treatment of Patients With Advanced Solid Tumors
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- Shanghai Miracogen Inc.
- Target Recruit Count
- 343
- Registration Number
- NCT07093970
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
🇨🇳Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China
Establishment of a Classification System and Postoperative Risk Warning Model for Patients Undergoing Bariatric Metabolic Surgery for Severe Obesity
Recruiting
- Conditions
- Bariatric Surgery (Sleeve Gastrectomy )ObesityBariatric Surgery
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Target Recruit Count
- 2000
- Registration Number
- NCT07093502
- Locations
- 🇨🇳
Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Comparison of Intrathecal Bupivacaine With and Without Morphine for Post-operative Analgesia in Parturients Undergoing Elective Cesarean Section: A Randomized Controlled Trial
Not Applicable
Not yet recruiting
- Conditions
- Cesarean DeliveryAnalgesia, ObstetricalPostoperative Pain
- Interventions
- Drug: Intrathecal morphine with bupivacaineDrug: Hyperbaric Bupivicaine
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- Tribhuvan University Teaching Hospital, Institute Of Medicine.
- Target Recruit Count
- 92
- Registration Number
- NCT07094802
A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- Guangzhou Virotech Pharmaceutical Co., Ltd.
- Target Recruit Count
- 42
- Registration Number
- NCT07093814
- Locations
- 🇨🇳
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Comparing the Extent to Which AQ280 is Made Available in the Body After Single Oral Doses of a Capsule Formulation Versus a Tablet for Oral Suspension Formulation
Not Applicable
Active, not recruiting
- Conditions
- Eosinophilic Esophagitis
- Interventions
- Drug: Placebo CapsuleDrug: AQ280 CapsuleDrug: Placebo Tablet for Oral SuspensionDrug: AQ280 Tablet for Oral Suspension
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- AQILION AB
- Target Recruit Count
- 9
- Registration Number
- NCT07093008
- Locations
- 🇺🇸
Clinical Research Site, Madison, Wisconsin, United States
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Not Applicable
Not yet recruiting
- Conditions
- Pancreatic Ductal AdenocarcinomaNon-Small-Cell Lung CancerColorectal CancerSolid Tumor
- Interventions
- Drug: ASP5834
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 364
- Registration Number
- NCT07094204
The Beneficial Effects on the Intestinal Function of a Food Supplement Based on an Extract of Green Tea and a Pool of Probiotics in Subjects With Irritable Bowel Syndrome With Predominance of Constipation
Not Applicable
Not yet recruiting
- Conditions
- IBS, Constipation Predominant
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- Adamas Biotech S.r.l.
- Target Recruit Count
- 64
- Registration Number
- NCT07094035
- Locations
- 🇮🇹
COMEGEN Soc. Coop. Sociale, Napoli, Italy
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Not Applicable
Not yet recruiting
- Conditions
- Alzheimer's Disease
- Interventions
- Other: Placebo
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 407
- Registration Number
- NCT07094516